Sandoz Confirms Launch Of Humira Rival In Canada
Introduction Of Hyrimoz Comes As Other Adalimumab Biosimilars Expected
Sandoz has confirmed the launch of its Hyrimoz biosimilar rival to Humira in Canada, with other biosimilars firms having also set their sights on a mid-February launch.
